FDA places clinical hold on VYNE's Phase 1b trial of VYN202 due to testicular toxicity seen in preclinical dog study. VYNE halts enrollment and dosing in psoriasis study; no serious adverse events reported in participants so far. Feel unsure about the market's next move?

NEW YORK, April 25, 2025 ( GLOBE NEWSWIRE ) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Cerevel Therapeutics Holdings, Inc. ( "Cerevel" or the "Company" ) CERE for violations of the ...

Foussemagne ( France ) , April 25, 2025 - 6:00 pm CEST - McPhy Energy, manufacturer of alkaline electrolyzers, today announces that it has made available to the public and filed with the Autorité des marchés financiers its 2024 annual report ( only available in French ) for the year ended ...

Maisons du Monde announces the release of its 2024 Universal Registration Document. The Document was filed with the Autorité des Marchés Financiers ( AMF ) this 25 April 2025, under the reference number D.25-0297.

NEW YORK, April 25, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ultra Clean Holdings, Inc. ( "Ultra Clean" or the "Company" ) UCTT. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ( or ...

First Hawaiian's FHB short percent of float has risen 4.07% since its last report. The company recently reported that it has 4.99 million shares sold short, which is 6.14% of all regular shares that are available for trading.

In the current market session, PG&E Inc. PCG share price is at $17.18, after a 1.18% decrease. Over the past month, the stock went up by 1.24%, but over the past year, it actually fell by 0.43%.

Globus Medical's GMED short percent of float has risen 36.6% since its last report. The company recently reported that it has 3.30 million shares sold short, which is 3.21% of all regular shares that are available for trading.

Flex's FLEX short percent of float has risen 18.23% since its last report. The company recently reported that it has 11.14 million shares sold short, which is 4.41% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.67 days to cover their ...

Deep-pocketed investors have adopted a bullish approach towards RH RH, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.